Marietta Wealth Management LLC Makes New $4.58 Million Investment in Stryker Corporation (NYSE:SYK)

Marietta Wealth Management LLC acquired a new position in shares of Stryker Corporation (NYSE:SYK - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 12,304 shares of the medical technology company's stock, valued at approximately $4,580,000.

A number of other large investors also recently made changes to their positions in SYK. Brighton Jones LLC increased its holdings in shares of Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company's stock valued at $1,643,000 after purchasing an additional 609 shares during the period. Global Retirement Partners LLC increased its holdings in shares of Stryker by 14.1% in the 4th quarter. Global Retirement Partners LLC now owns 7,052 shares of the medical technology company's stock valued at $2,539,000 after purchasing an additional 869 shares during the period. Private Advisor Group LLC increased its holdings in shares of Stryker by 0.4% in the 4th quarter. Private Advisor Group LLC now owns 16,027 shares of the medical technology company's stock valued at $5,771,000 after purchasing an additional 60 shares during the period. Concurrent Investment Advisors LLC increased its holdings in shares of Stryker by 13.8% in the 4th quarter. Concurrent Investment Advisors LLC now owns 8,575 shares of the medical technology company's stock valued at $3,087,000 after purchasing an additional 1,040 shares during the period. Finally, Mattern Capital Management LLC increased its holdings in shares of Stryker by 2.0% in the 4th quarter. Mattern Capital Management LLC now owns 26,622 shares of the medical technology company's stock valued at $9,585,000 after purchasing an additional 515 shares during the period. Institutional investors and hedge funds own 77.09% of the company's stock.

Insider Activity

In other news, Director Ronda E. Stryker sold 200,000 shares of the stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the sale, the director now directly owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 5.90% of the stock is owned by company insiders.

Stryker Trading Up 0.6%

Shares of SYK stock opened at $375.44 on Friday. Stryker Corporation has a 12 month low of $314.93 and a 12 month high of $406.19. The company has a quick ratio of 1.00, a current ratio of 1.64 and a debt-to-equity ratio of 0.69. The business's 50 day moving average is $374.95 and its two-hundred day moving average is $375.30. The company has a market cap of $143.30 billion, a PE ratio of 50.73, a price-to-earnings-growth ratio of 2.81 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, beating the consensus estimate of $2.73 by $0.11. Stryker had a return on equity of 23.74% and a net margin of 12.31%. The company had revenue of $5.87 billion for the quarter, compared to the consensus estimate of $5.68 billion. During the same quarter last year, the company posted $2.50 earnings per share. The company's revenue for the quarter was up 11.9% compared to the same quarter last year. Equities analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a $0.84 dividend. The ex-dividend date of this dividend is Monday, June 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.89%. Stryker's dividend payout ratio is 45.41%.

Analysts Set New Price Targets

SYK has been the topic of a number of research reports. Sanford C. Bernstein set a $450.00 target price on Stryker in a report on Monday, May 5th. Needham & Company LLC restated a "buy" rating and issued a $442.00 price objective on shares of Stryker in a report on Friday, March 21st. Evercore ISI dropped their price objective on Stryker from $400.00 to $390.00 and set an "outperform" rating on the stock in a report on Friday, May 2nd. BTIG Research set a $403.00 price objective on Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, The Goldman Sachs Group set a $422.00 price objective on Stryker in a report on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $427.30.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.